13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Molecular Neuroscience
Molecular neuroscience focuses on understanding the molecular basis of brain function and neurological diseases. This field investigates how molecules such as proteins, RNA, and lipids influence neural processes like synaptic transmission, neural growth, and plasticity. The study of ion channels, receptors, and intracellular signaling pathways is crucial for understanding both normal brain function and disease states. Recent advances in molecular technologies have allowed for the identification of new biomarkers and therapeutic targets for diseases like multiple sclerosis and amyotrophic lateral sclerosis (ALS). Additionally, research in molecular neuroscience is exploring how genetic mutations and environmental factors interact at the molecular level, offering promising avenues for personalized medicine in neurological care.
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
George Diaz
Memorial Healthcare Systems, United States
Daniel Curry
Texas Children’s Hospital, United States
Zhenhuan Liu
Guangzhou University Chinese Medicine, China
Kiran Ghotra
Lake Erie College of Osteopathic Medicine, United States
Maryam Golmohammadi
UCLA Doheny Eye Institute, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A Case Report
George Diaz, Memorial Healthcare Systems, United States
Title : What we don’t know about hydrocephalus and It’s management
Daniel Curry, Texas Children’s Hospital, United States
Title : Artificial intelligence-driven DWI and FLAIR for the detection of early stroke changes: A systematic review
Shari L Guerra, The Medical City, Philippines
Title : Mapping neuroplasticity in occupational therapy: Evidence-based interventions with measurable neural outcomes
Jessica Marchant, Texas Woman's University, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Nanoparticles passing the blood brain barrier to treat cancer, infection, and more
Thomas J Webster, Brown University, United States